These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 39125620

  • 1. Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.
    Santos-Gomes J, Mendes-Ferreira P, Adão R, Maia-Rocha C, Rego B, Poels M, Saint-Martin Willer A, Masson B, Provencher S, Bonnet S, Montani D, Perros F, Antigny F, Leite-Moreira AF, Brás-Silva C.
    Int J Mol Sci; 2024 Jul 24; 25(15):. PubMed ID: 39125620
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y, Okumura K, Ishii R, Slorach C, Hui W, Ide H, Honjo O, Sun M, Kabir G, Connelly K, Friedberg MK.
    J Appl Physiol (1985); 2020 Aug 01; 129(2):238-246. PubMed ID: 32644912
    [Abstract] [Full Text] [Related]

  • 3. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED, Hardie BA, Garcia KM, Mu H, Wang TM, Valdez-Jasso D.
    Am J Physiol Heart Circ Physiol; 2024 Aug 01; 327(2):H351-H363. PubMed ID: 38847755
    [Abstract] [Full Text] [Related]

  • 4. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Pimentel LD, Monteiro-Pinto C, Mulvaney EP, Reid HM, Kinsella BT, Potus F, Breuils-Bonnet S, Rademaker MT, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C.
    Cardiovasc Res; 2018 Jul 01; 114(8):1165-1177. PubMed ID: 29584808
    [Abstract] [Full Text] [Related]

  • 5. CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Zhang X, Qin H, Ma Q, Zhang J, Tian H, Meng Y.
    Clin Respir J; 2024 May 01; 18(5):e13771. PubMed ID: 38747117
    [Abstract] [Full Text] [Related]

  • 6. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A, Colombo R, Siqueira R, Campos-Carraro C, Turck P, Luz de Castro A, Belló-Klein A, Sander da Rosa Araujo A.
    J Cardiovasc Pharmacol; 2024 Jun 01; 83(6):612-620. PubMed ID: 38547510
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
    Li P, Song J, Du H, Lu Y, Dong S, Zhou S, Guo Z, Wu H, Zhao X, Qin Y, Zhu N.
    J Mol Cell Cardiol; 2021 Dec 01; 161():9-22. PubMed ID: 34339758
    [Abstract] [Full Text] [Related]

  • 8. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G, Wang X, Li Y, He L.
    Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784
    [Abstract] [Full Text] [Related]

  • 9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.
    Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924
    [Abstract] [Full Text] [Related]

  • 10. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S, Peng F, Li ML, Duan WB, Peng CQ, Wu SJ.
    Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H377-H391. PubMed ID: 32559140
    [Abstract] [Full Text] [Related]

  • 11. miR-223 reverses experimental pulmonary arterial hypertension.
    Meloche J, Le Guen M, Potus F, Vinck J, Ranchoux B, Johnson I, Antigny F, Tremblay E, Breuils-Bonnet S, Perros F, Provencher S, Bonnet S.
    Am J Physiol Cell Physiol; 2015 Sep 15; 309(6):C363-72. PubMed ID: 26084306
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Xbp1s-Ddit3 promotes MCT-induced pulmonary hypertension.
    Jiang H, Ding D, He Y, Li X, Xu Y, Liu X.
    Clin Sci (Lond); 2021 Nov 12; 135(21):2467-2481. PubMed ID: 34676402
    [Abstract] [Full Text] [Related]

  • 14. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov 12; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P, Santos-Ribeiro D, Adão R, Maia-Rocha C, Mendes-Ferreira M, Sousa-Mendes C, Leite-Moreira AF, Brás-Silva C.
    Am J Physiol Heart Circ Physiol; 2016 Jul 01; 311(1):H85-95. PubMed ID: 27199115
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.